L'Oreal CO ADR (LRLCY)
$54.12 0.00 (0.00%)
15:59 EST LRLCY Stock Quote Delayed 15 Minutes
Previous Close $54.12
Market Cap 151.22B
PE Ratio -
Volume (Avg. Vol.)
Day's Range 54.12 - 54.12
52-Week Range 49.76 - 61.19
Dividend & Yield 0.67 (1.24%)
LRLCY Stock Predictions, Articles, and L'Oreal CO ADR News
- From InvestorPlace
- From the Web
Valeant still needs to show it can execute, so now would be the time for those who bought VRX stock at the lows to take some profits.
Pandora (P) stock jumps on reports of its CEO's departure, GrubHub (GRUB) is downgraded and Nestle (NSRGY) finds itself in Dan Loeb's crosshairs.
Valeant Pharmaceuticals (VRX) finds relief as John Paulson joins the board, but what can he really do to help VRX stock holders?
VRX stock has emerged as one of Thursday's big winners, but it would be wise to crunch the numbers of the deal Valeant Pharmaceuticals just made.
Valeant earnings are due out Tuesday morning, but it would take a laundry list of good news to sustain the rally in VRX stock.
Valeant Pharmaceuticals (VRX) might have a shiny new turnaround plan, but VRX stock is anything but new and improved.
Has Valeant Pharmaceuticals (VRX) turned the corner with its latest asset sales? Or is VRX stock still heading ever closer to zero?
Valeant Pharmaceuticals' (VRX) asset sales could be the start of a breakup. Speculators who get into VRX stock now can still reap rewards.